The 15th Anniversary of Pharmaceutics—Advances and Future Trends in Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 July 2024) | Viewed by 8718
Special Issue Editors
Interests: molecularly imprinted polymers; drug delivery; drug targeting; theranostics; functional polymers; stimuli-responsive polymers; biomaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The year 2023 marks the 15th anniversary of Pharmaceutics, and to celebrate this significant milestone, we aim to publish a Special Issue entitled “The 15th Anniversary of Pharmaceutics—Advances and Future Trends in Drug Delivery”.
Drug delivery can be defined as the process or method of administering a pharmaceutical compound to achieve a therapeutic effect both in humans or animals. The form in which a therapeutic agent is administered can exert an important impact on its efficacy and safety; thus, the use of suitable drug delivery systems (DDSs) can enhance both, leading to improved patient compliance.
In addition, the development of new drug molecules is expensive and time consuming, and DDSs represent new promising tools that can give a new life to old drugs by enabling controlled and/or targeted delivery, individualized therapy, real-time monitoring of therapeutic efficacy, improvements in stability, and the repositioning of exiting drugs for new therapeutic purposes.
In this Special Issue, original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Ortensia Ilaria Parisi
Dr. Marco Dattilo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery
- drug targeting
- theranostics
- nanotechnology
- in vitro and in vivo drug delivery model development
- drug repurposing
- stimuli-responsive systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.